Company / Operating Income per Share
Corcept Therapeutics Incorporated Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.43
FY2025
5-year range
$0.43 / $1.32
FY2021-FY2025
Trend
-67.8%
vs FY2024
Sector context
#47 of 201
Health Care
What the data says
Corcept Therapeutics Incorporated's operating income per share of $0.43 is higher than 77% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-0.25 in FY2016 to $1.32 in FY2024.
Based on SEC 10-K filings.
0.43 in FY2025 with a 5-year CAGR of -11.4%. Top quartile in the Health Care sector.
Declined from $0.99 to $0.43 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -29.4%
- 5-Year CAGR
- -11.4%
- 10-Year CAGR
- -
Sector benchmark
+113.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 67.8% year-over-year.
- Ranks #47 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.43 | -67.8% |
| FY2024 | $1.32 | +33.1% |
| FY2023 | $0.99 | -17.8% |
| FY2022 | $1.21 | +26.6% |
| FY2021 | $0.96 | +22.4% |
| FY2020 | $0.78 | +70.0% |
| FY2019 | $0.46 | +417.8% |
| FY2018 | $0.09 | -81.1% |
| FY2017 | $0.47 | +286.2% |
| FY2016 | -$0.25 | -641.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026